HOPKINTON, Mass., Feb. 24 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. , a leading provider of tools and services for drug discovery and life sciences research, and its wholly owned subsidiary Xenogen Corporation, today announced the filing of a patent infringement lawsuit in the U.S. District Court for the Eastern District of Texas. In the suit, filed with Stanford as a co-plaintiff, Caliper Life Sciences and Xenogen seek a finding of willful infringement by Carestream Health, Inc. of Rochester, NY, compensatory damages, a trebling due to willfulness, a permanent injunction and attorneys' fees against Carestream for the ongoing, unauthorized and willful use of a number of United States patents that Caliper, through Xenogen, exclusively licenses from Stanford University.
Caliper Life Sciences, Inc. and Xenogen Corporation are represented in this litigation by Washington, DC-based intellectual property specialty law firm Sterne, Kessler, Goldstein & Fox P.L.L.C. and Tyler, TX-based litigation firm Wilson, Robertson & Cornelius, P.C.
CONTACT: Peter McAree, SVP and Chief Financial Officer, Caliper Life
Sciences, +1-508-497-2215; or Media Contact: Ben Navon, or Kristin
Villiotte, both of Schwartz Communications, +1-781-684-0770,
caliper@schwartz-pr.com
Web site: http://www.caliperls.com/
